Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early versus threshold-triggered vasopressin in shock-related hypotension
ACTRN12625000713493Phase 4Not yet recruiting
- Sponsor
- Sunshine Coast University Hospital
- Start
- Jul 2025
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of vasopressin and norepinephrine in Shock, hypotension, sepsis and 1 more (2 arms), sponsored by Sunshine Coast University Hospital. Primary endpoint: Total duration of pressor requirement. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
vasopressinnorepinephrine
03
Conditions
Shockhypotensionsepsiscardiogenic shock
Beyond the preview
Go deeper on ACTRN12625000713493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625000713493.